Home
/
Burning Rock Biotech Limited (BNR)
Burning Rock Biotech Limited (BNR) Technical Analysis
Updated: 2026-03-17 00:39 UTC · Last close: 16.99 (+6.12%)
Burning Rock Biotech Limited (BNR) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
The latest close for Burning Rock Biotech Limited (BNR) came in at 16.99 (+6.12%). The chart is sitting below its 50-day average while still holding above the 200-day average, suggesting shorter-term weakness inside a still positive long-term backdrop. 20-day momentum is notably weak at -41.69%; price remains inside its roughly 52-week range (2.32–41.06); and ATR14 volatility is elevated at roughly 13.45% of price. RSI(14) sits near 31.0, which signals relatively weak momentum conditions. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Recent trading volume is running well above its 20-day average, which suggests strong participation behind the latest price moves. Pattern signals currently detected: Double top, Cup & handle. Near-term structure is defined by support at 14.25 and resistance at 17.20. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 70.67M · Net income: -47.49M. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
Fundamentals Snapshot
Source: sec
Company
Burning Rock Biotech Limited
Note: This is an algorithmic technical snapshot (not financial advice).